News
-
Federal Council wants to maintain security of supply for medical devices
-
Covid-19: Federal authorities want to increase use of scientific knowledge
-
Covid-19: Federal authorities have adequately examined Covid-19 measures for constitutionality
-
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC)
-
Healthcare: Medical Devices 2023 – Chapter Switzerland
-
Federal Council promotes generics and access to essential medicines
-
Sharply surging costs lead to significantly higher health insurance premiums in 2024
-
Swissmedic offers Scientific Advice for Weight-of-Evidence Approach described in the Addendum of the S1B(R1) Guideline on testing for carcinogenicity of pharmaceuticals of the International Council for Harmonisation of Technical Requirements for Registrat
-
Frequently Asked Questions General Pharmacovigilance
-
Swissmedic approves Moderna Switzerland GmbH coronavirus vaccine Spikevax XBB.1.5
-
Swiss pharmaceutical reimbursement and pricing: The Ordinance on Health Insurance (HIO) and the Ordinance on Healthcare Benefits (Krankenpflege-Leistungsverordung, KLV) will change as of January 2024
-
Daily allowances in the event of a relapse following an accident not originally insured under the Accident Insurance Act (AIA): The Federal Council opens the consultation procedure
-
Changes to the guidance document Temporary authorisation of human medicinal products
-
Spikevax: European Medicines Agency (EMA) recommends approval of adapted COVID-19 vaccine targeting Omicron XBB.1.5
-
European Medicines Agency (EMA) recommends non-renewal of authorisation of Duchenne muscular dystrophy medicine Translarna
-
European Medicines Agency (EMA) recommends non-renewal of authorisation of multiple myeloma medicine Blenrep
-
Towards a permanent collaboration framework for European Medicine Agency (EMA) and Health Technology Assessment bodies
-
Decision C-3051/2021 dated 25 August 2023
-
Covid-19: Vaccination recommended for people at particular risk to protect against severe disease
-
Outpatient physiotherapy: What's next?
-
Swiss Good Manufacturing and Distribution Practice (SwissGMDP) database